NYSE:ABBV - AbbVie Inc.
$70.58
 $0.07
+0.10%
4:00PM EDT
2019-09-16
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ABBV     avg for
industry  
  avg for
sector  
42 stocks weight:  187. 52   0. 00   0. 00  
42 stocks rank:  1. 63 K 1. 97 K 1. 30 K
# analyst opinions:  12. 00   12. 84   12. 97  
mean recommendation:  2. 50   2. 12   2. 07  

quick ratio:  0. 64   5. 11   1. 92  
current ratio:  0. 89   5. 50   2. 45  

ex-dividend date:     2019-10-10
dividend rate:  4. 28   1. 27   1. 62  
dividend yield:  6. 04 % 1. 97 % 1. 84 %
target price low:  74. 00   79. 53   109. 66  
target price avg:  86. 58   100. 11   131. 81  
target price high:  130. 00   126. 46   149. 31  
1-yr high:  96. 01   104. 28   134. 46  
last close:  70. 58   77. 07   117. 08  
50-day avg:  67. 25   79. 01   117. 12  
200-day avg:  77. 71   81. 51   113. 76  
1-yr low:  62. 98   62. 18   93. 76  
volume:  7. 92 M 2. 53 M 3. 04 M
50-day avg volume:  9. 27 M 3. 41 M 4. 09 M
200-day avg volume:  7. 80 M 3. 18 M 4. 63 M

1-day return:  -1. 21 % -0. 17 % 0. 18 %
this week return:  0. 10 % 0. 31 % 0. 77 %
12-wk return:  -2. 94 % -0. 76 % 2. 99 %
52-wk return:  -25. 73 % -5. 78 % 4. 64 %

enterprise value (EV):  136. 62 B 44. 28 B 112. 94 B
market cap:  104. 35 B 500. 31 B 4. 95 T
EBITDA:  14. 92 B 4. 78 B 7. 74 B
enterprise multiple (EV/EBITDA):  9. 15   2. 41   10. 42  
enterprise/revenue (EV/R):  4. 19   150. 10   22. 18  
total revenue:  32. 62 B 10. 73 B 31. 64 B
total debt:  37. 79 B 11. 92 B 16. 97 B
net income (common):  4. 09 B 1. 86 B 3. 90 B

shares outstanding:  1. 48 B 579. 09 M 1. 27 B
shares:  1. 48 B 584. 68 M 1. 22 B
shares short:  51. 01 M 16. 45 M 13. 52 M
shares short prior month:  44. 17 M 15. 17 M 12. 50 M
short ratio:  5. 09   6. 82   3. 68  
short % of float:  3. 91 % 7. 00 % 2. 78 %
total cash/share:  3. 66   10. 27   8. 82  
total cash:  5. 42 B 6. 23 B 5. 99 B
free cash flow:  9. 81 B 2. 91 B 4. 78 B
operating cash flow:  13. 41 B 4. 10 B 5. 77 B

book value:  -5. 79   13. 01   26. 68  
price/book:  -12. 18   -9. 86   6. 12  
gross profits:  25. 04 B 8. 13 B 35. 94 B
operating margins:  39. 97 % -1246. 94 % -202. 61 %
EBITDA margins:  45. 74 % 7. 07 % 24. 32 %
profit margins:  12. 62 % 3. 12 % 14. 56 %
gross margins:  77. 41 % 44. 41 % 58. 52 %

1-yr max volatility:  16. 16 % --- ---
1-yr mean volatility:  1. 29 % 1. 19 % 0. 86 %

1-yr EPS:  2. 74   1. 30   4. 02  
forward EPS:  9. 49   3. 42   6. 65  
P/E:  25. 77   15. 96   23. 91  
forward P/E:  7. 43   -4. 28   12. 40  
PE/G:  -1. 62   1. 02   -1. 71  
growth:  -15. 88 % 218. 69 % 102. 21 %
earnings high:  2. 38   1. 22   1. 61  
earnings avg:  2. 29   0. 85   1. 50  
earnings low:  2. 18   0. 55   1. 39  
revenue high:  8. 45 B 2. 88 B 8. 82 B
revenue avg:  8. 37 B 2. 80 B 8. 66 B
revenue low:  8. 31 B 2. 75 B 8. 48 B
earnings growth:  -61. 10 % -9. 46 % 138. 30 %
1-qtr earnings growth:  -62. 60 % -9. 79 % 256. 65 %
return on assets:  13. 72 % -2. 87 % 5. 55 %
revenue growth:  -0. 30 % 222. 79 % 39. 99 %
revenue/share:  21. 87   13. 15   52. 14  

beta (1yr vs S&P500):  0. 91   1. 20   0. 87  
sharpe (1yr):  -0. 72   -0. 09   0. 48  

held % insiders:  0. 08 % 6. 78 % 3. 59 %
held % institutions:  71. 89 % 76. 29 % 67. 25 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-09-16 : ABBV
.    145.581 =         145.581 :: --> INITIAL WEIGHT <--
.                               --> FUNDAMENTALS <--
.    x 2.335 =         339.896 :: P/E factor
.    x 0.984 =         334.443 :: PE/G factor
.    x 1.656 =         553.989 :: beta factor
.    x 0.961 =         532.262 :: sharpe factor
.    x 1.209 =         643.512 :: current ratio factor
.     x 0.95 =         611.201 :: quick ratio factor
.    x 1.117 =         682.855 :: short ratio factor
.    x 1.167 =         796.856 :: return on assets factor
.    x 0.914 =         728.378 :: earnings growth factor
.    x 2.261 =        1647.075 :: EV/R factor
.    x 0.944 =        1555.393 :: enterprise-to-EBITDA factor
.    x 0.904 =        1406.788 :: enterprise-multiple vs industry factor
.    x 0.981 =        1379.758 :: debt-to-revenue factor
.                               --> PERFORMANCE <--
.    x 2.037 =        2811.235 :: sector+industry 1-year gains factor
.    x 0.979 =         2751.18 :: industry 12-weeks return factor
.    x 1.315 =        3618.849 :: industry 2-weeks return factor
.    x 0.985 =        3563.834 :: company one-year gains+dividend factor
.    x 5.978 =       21304.832 :: company 13 weeks' performance factor
.    x 1.166 =       24848.409 :: 5-day avg > 50-day avg
.    x 0.997 =       24772.148 :: "drift" penalty 5 days ago
.    x 4.679 =      115908.984 :: overall "drift" factor
.    x 0.974 =        112881.5 :: largest single-day price delta factor
.    x 0.998 =      112676.462 :: volatility factor
.    x 0.999 =      112507.925 :: 42-day volatility factor
.    x 6.212 =      698950.422 :: notable returns (1) + performance factor
.    x 2.199 =     1536789.075 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 1.709 =     2626011.937 :: forward EPS factor
.    x 1.453 =     3814523.144 :: forward P/E factor
.    x 1.183 =     4513021.036 :: industry recommendation factor
.     x 1.89 =     8527733.958 :: company recommendation factor
.    x 1.006 =     8583013.526 :: factor historical industry gain for week 37
.    x 1.273 =    10927161.373 :: target low factor
.    x 1.159 =    12661385.669 :: target mean factor
.    x 1.039 =    13149313.988 :: target high factor
.   x 10.479 =   137795430.969 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         108.345 :: reduced for readability
.   + 79.176 =         187.521 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                    187.521 :: FINAL WEIGHT for NYSE:ABBV


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org